Bioxyne (BXN.AX) Stock Price

Bioxyne Price

ASX·CLOSED
0.83AUD+0.02 (+2.44 %)
Market closed

Revenue has compounded at 15.9% per year over the past 19 years to 28.43 M AUD. Earnings per share have declined at 3.4% per year over the last 15 years. Bioxyne's net margin stands at 17.2%, up from -23.5% several years earlier. The stock trades about 152% above its 52-week low.

Bioxyne stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Bioxyne over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Bioxyne stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Bioxyne's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Bioxyne Stock Price History
DateBioxyne Price
8/3/20260.83 AUD
7/31/20260.81 AUD
7/30/20260.80 AUD
7/29/20260.78 AUD
7/28/20260.81 AUD
7/27/20260.81 AUD
7/24/20260.84 AUD
7/23/20260.85 AUD
7/22/20260.86 AUD
7/21/20260.84 AUD
7/20/20260.89 AUD
7/17/20260.87 AUD
7/16/20260.93 AUD
7/15/20260.94 AUD
7/14/20260.97 AUD
7/13/20260.97 AUD
7/10/20260.90 AUD
7/9/20260.81 AUD
7/8/20260.81 AUD
7/7/20260.93 AUD
7/6/20260.93 AUD
7/3/20260.93 AUD
7/2/20260.93 AUD
7/1/20260.93 AUD
6/30/20260.93 AUD
6/29/20260.94 AUD
6/26/20260.95 AUD
6/25/20260.95 AUD
6/24/20260.97 AUD
6/23/20261.00 AUD
6/22/20260.97 AUD
6/19/20261.05 AUD
6/18/20260.96 AUD
6/17/20261.00 AUD
6/16/20260.93 AUD
6/15/20260.94 AUD
6/12/20260.86 AUD
6/11/20260.86 AUD
6/10/20260.86 AUD
6/9/20260.92 AUD
6/5/20260.86 AUD
6/4/20260.87 AUD
6/3/20260.78 AUD
6/2/20260.75 AUD
6/1/20260.81 AUD
5/29/20260.80 AUD
5/28/20260.78 AUD
5/27/20260.77 AUD
5/26/20260.80 AUD
5/25/20260.69 AUD
5/22/20260.68 AUD
5/21/20260.74 AUD
5/20/20260.76 AUD
5/19/20260.73 AUD
5/18/20260.75 AUD
5/15/20260.83 AUD
5/14/20260.84 AUD
5/13/20260.83 AUD
5/12/20260.89 AUD
5/11/20260.72 AUD
5/8/20260.70 AUD
5/7/20260.65 AUD
5/6/20260.63 AUD
5/5/20260.60 AUD
5/4/20260.58 AUD
5/1/20260.57 AUD
4/30/20260.58 AUD
4/29/20260.60 AUD
4/28/20260.58 AUD
4/27/20260.65 AUD
4/24/20260.66 AUD
4/23/20260.70 AUD
4/22/20260.74 AUD
4/21/20260.76 AUD
4/20/20260.77 AUD
4/17/20260.69 AUD
4/16/20260.67 AUD
4/15/20260.68 AUD
4/14/20260.69 AUD
4/13/20260.64 AUD
4/10/20260.66 AUD
4/9/20260.65 AUD
4/8/20260.61 AUD
4/7/20260.60 AUD
4/2/20260.64 AUD
4/1/20260.64 AUD
3/31/20260.63 AUD
3/30/20260.57 AUD
3/27/20260.60 AUD
3/26/20260.57 AUD
3/25/20260.53 AUD
3/24/20260.47 AUD
3/23/20260.50 AUD
3/20/20260.51 AUD
3/19/20260.50 AUD
3/18/20260.50 AUD
3/17/20260.50 AUD
3/16/20260.48 AUD
3/13/20260.54 AUD
3/12/20260.55 AUD
3/11/20260.56 AUD
3/10/20260.58 AUD
3/9/20260.54 AUD
3/6/20260.59 AUD
3/5/20260.60 AUD
3/4/20260.56 AUD
3/3/20260.59 AUD
3/2/20260.60 AUD
2/27/20260.60 AUD
2/26/20260.60 AUD
2/25/20260.52 AUD
2/24/20260.48 AUD
2/23/20260.47 AUD
2/20/20260.45 AUD
2/19/20260.46 AUD
2/18/20260.45 AUD
2/17/20260.46 AUD
2/16/20260.48 AUD
2/13/20260.48 AUD
2/12/20260.46 AUD
2/11/20260.48 AUD
2/10/20260.45 AUD
2/9/20260.42 AUD
2/6/20260.40 AUD
2/5/20260.43 AUD
2/4/20260.40 AUD
2/3/20260.40 AUD
2/2/20260.39 AUD
1/30/20260.39 AUD
1/29/20260.40 AUD
1/28/20260.39 AUD
1/27/20260.42 AUD
1/23/20260.40 AUD
1/22/20260.41 AUD
1/21/20260.38 AUD
1/20/20260.38 AUD
1/19/20260.40 AUD
1/16/20260.40 AUD
1/15/20260.37 AUD
1/14/20260.37 AUD
1/13/20260.37 AUD
1/12/20260.38 AUD
1/9/20260.38 AUD
1/8/20260.39 AUD
1/7/20260.40 AUD
1/6/20260.40 AUD
1/5/20260.41 AUD
1/2/20260.41 AUD
12/31/20250.42 AUD
12/30/20250.42 AUD
12/29/20250.42 AUD
12/24/20250.42 AUD
12/23/20250.42 AUD
12/22/20250.42 AUD
12/19/20250.42 AUD
12/18/20250.43 AUD
12/17/20250.43 AUD
12/16/20250.43 AUD
12/15/20250.43 AUD
12/12/20250.39 AUD
12/11/20250.38 AUD
12/10/20250.37 AUD
12/9/20250.38 AUD
12/8/20250.37 AUD
12/5/20250.38 AUD
12/4/20250.35 AUD
12/3/20250.36 AUD
12/2/20250.36 AUD
12/1/20250.37 AUD
11/28/20250.37 AUD
11/27/20250.36 AUD
11/26/20250.37 AUD
11/25/20250.36 AUD
11/24/20250.37 AUD
11/21/20250.38 AUD
11/20/20250.37 AUD
11/19/20250.38 AUD
11/18/20250.36 AUD
11/17/20250.37 AUD
11/14/20250.39 AUD
11/13/20250.38 AUD
11/12/20250.40 AUD
11/11/20250.40 AUD
11/10/20250.40 AUD
11/7/20250.39 AUD
11/6/20250.41 AUD
11/5/20250.40 AUD
11/4/20250.38 AUD
11/3/20250.39 AUD
10/31/20250.40 AUD
10/30/20250.40 AUD
10/29/20250.41 AUD
10/28/20250.41 AUD
10/27/20250.43 AUD
10/24/20250.42 AUD
10/23/20250.39 AUD
10/22/20250.38 AUD
10/21/20250.39 AUD
10/20/20250.37 AUD
10/17/20250.39 AUD
10/16/20250.39 AUD
10/15/20250.38 AUD
10/14/20250.35 AUD
10/13/20250.33 AUD
10/10/20250.37 AUD
10/9/20250.37 AUD
10/8/20250.36 AUD
10/7/20250.37 AUD
10/6/20250.39 AUD
10/3/20250.39 AUD
10/2/20250.41 AUD
10/1/20250.41 AUD
9/30/20250.38 AUD
9/29/20250.39 AUD
9/26/20250.42 AUD
9/25/20250.39 AUD
9/24/20250.39 AUD
9/23/20250.38 AUD
9/22/20250.38 AUD
9/19/20250.41 AUD
9/18/20250.42 AUD
9/17/20250.44 AUD
9/16/20250.44 AUD
9/15/20250.42 AUD
9/12/20250.40 AUD
9/11/20250.41 AUD
9/10/20250.45 AUD
9/9/20250.43 AUD
9/8/20250.46 AUD
9/5/20250.45 AUD
9/4/20250.47 AUD
9/3/20250.43 AUD
9/2/20250.46 AUD
9/1/20250.48 AUD
8/29/20250.50 AUD
8/28/20250.58 AUD
8/27/20250.58 AUD
8/26/20250.57 AUD
8/25/20250.54 AUD
8/22/20250.55 AUD
8/21/20250.57 AUD
8/20/20250.53 AUD
8/19/20250.53 AUD
8/18/20250.53 AUD
8/15/20250.53 AUD
8/14/20250.51 AUD
8/13/20250.51 AUD
8/12/20250.52 AUD
8/11/20250.53 AUD
8/8/20250.51 AUD
8/7/20250.49 AUD
8/6/20250.47 AUD
Access this data via the Eulerpool API
Get Free API Key

Bioxyne Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
1.99 M AUD
-1.58 M AUD
-1.31 M AUD
Jan 1, 2019
2.13 M AUD
-1.47 M AUD
-1.27 M AUD
Jan 1, 2020
2.26 M AUD
-514,200.00 AUD
-593,100.00 AUD
Jan 1, 2021
2.11 M AUD
-347,400.00 AUD
-495,700.00 AUD
Jan 1, 2022
463,600.00 AUD
-454,400.00 AUD
-494,000.00 AUD
Jan 1, 2023
5.15 M AUD
-2.00 M AUD
-1.94 M AUD
Jan 1, 2024
9.33 M AUD
-1.66 M AUD
-13.33 M AUD
Jan 1, 2025
28.43 M AUD
4.03 M AUD
4.90 M AUD

Bioxyne Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 5, 2026, 9:40 PM
 
REVENUEM AUD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM AUD
EBITM AUD
EBIT MARGIN%
NET INCOMEM AUD
NET INCOME GROWTH%
SHARESB
2010201120122013201420152016201720182019202020212022202320242025
––1.001.002.001.001.001.001.002.002.002.00–5.009.0028.00
––––100.00-50.00–––100.00––––80.00211.11
––100.001,000.0050.001,000.00100.001,000.001,000.0050.0050.0050.00–20.0033.3335.71
10.0010.001.0010.001.0010.001.0010.0010.001.001.001.0010.001.003.0010.00
––-4.00-1.00––––-1.00-1.00–––-2.00-1.004.00
––-400.00-100.00––––-100.00-50.00–––-40.00-11.1114.29
––-1.00-6.001.00–––-1.00-1.00–––-1.00-13.004.00
–––500.00-116.67–––––––––1,200.00-130.77
0.020.020.070.220.260.290.290.240.590.640.640.640.731.341.932.15
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Bioxyne generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Bioxyne retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Bioxyne's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Bioxyne has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Bioxyne's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Bioxyne stock margins

The Bioxyne margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bioxyne. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bioxyne.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
47.04 %
-79.33 %
-65.86 %
Jan 1, 2019
53.57 %
-69.06 %
-59.36 %
Jan 1, 2020
53.78 %
-22.76 %
-26.25 %
Jan 1, 2021
51.24 %
-16.46 %
-23.49 %
Jan 1, 2022
29.10 %
-98.02 %
-106.56 %
Jan 1, 2023
27.58 %
-38.84 %
-37.64 %
Jan 1, 2024
36.44 %
-17.79 %
-142.90 %
Jan 1, 2025
36.32 %
14.17 %
17.24 %

Bioxyne Stock Revenue, EBIT, Earnings per Share

The Bioxyne earnings per share therefore indicates how much revenue Bioxyne has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
0.00 AUD
-0.00 AUD
-0.00 AUD
Jan 1, 2019
0.00 AUD
-0.00 AUD
-0.00 AUD
Jan 1, 2020
0.00 AUD
-0.00 AUD
-0.00 AUD
Jan 1, 2021
0.00 AUD
-0.00 AUD
-0.00 AUD
Jan 1, 2022
0.00 AUD
-0.00 AUD
-0.00 AUD
Jan 1, 2023
0.00 AUD
-0.00 AUD
-0.00 AUD
Jan 1, 2024
0.00 AUD
-0.00 AUD
-0.01 AUD
Jan 1, 2025
0.01 AUD
0.00 AUD
0.00 AUD

Bioxyne business model & stock analysis

Bioxyne Ltd is an Australian biotechnology company that was founded in 2000. Bioxyne's business model focuses on the discovery, development, and marketing of innovative, turnkey biological products and services to improve consumers' health and well-being. Bioxyne has four different business divisions: natural products, health and wellness products, veterinary products, and contract research services. In the natural products division, Bioxyne offers a portfolio of products based on natural ingredients, such as probiotics, superfood powders, herbal extracts, and dietary supplements. These products are designed to strengthen the immune system, promote gut health and digestion, and support a healthy lifestyle. Bioxyne's health and wellness product division offers a wide range of innovative products aimed at improving the health and well-being of people, such as vitamins, dietary supplements, skincare products, and anti-aging products. Bioxyne utilizes the latest biotechnological research to manufacture these products tailored to the needs of customers worldwide. The veterinary product division of Bioxyne is dedicated to improving the health and well-being of pets, livestock, and other animals. Bioxyne offers a wide range of animal health products, including dietary supplements to enhance immune system and skin and hair health, as well as products supporting digestion, metabolism, and cognitive functions in animals. Bioxyne's contract research service division specializes in providing customized and turnkey biological services and products to customers in the pharmaceutical industry, food industry, and veterinary medicine. Bioxyne has an experienced team of scientists and researchers specialized in conducting research and development services in the field of biotechnology. Some of Bioxyne's notable products include the probiotic Nuflora, used to support and improve gut health, the natural dietary supplement Ceramosides, which has strong anti-aging effects due to its formula, and the superfood powder blend Health 365, which contains all the essential nutrients needed to support a healthy lifestyle. Overall, Bioxyne offers a wide range of biotechnological products and services tailored to the needs of customers worldwide. The company is committed to incorporating the latest biotechnological advancements into its products and offering its customers innovative and high-quality solutions to improve health and well-being.

Bioxyne SWOT Analysis

Strengths

1. Market-leading products: Bioxyne Ltd offers a range of innovative and high-quality healthcare solutions.

2. Strong brand reputation: The company is well-known and trusted by healthcare professionals and consumers.

3. Robust research and development (R&D) capabilities: Bioxyne Ltd invests heavily in R&D to develop new and improved products.

Weaknesses

1. Limited market presence: Bioxyne Ltd currently operates in a niche market, which hampers its growth potential.

2. Relatively small customer base: The company may face challenges in expanding its customer reach and acquiring new customers.

3. Dependence on key suppliers: Any disruption in the supply chain could negatively impact the company's operations.

Opportunities

1. Growing demand for natural healthcare products: Bioxyne Ltd can capitalize on the increasing preference for natural and organic products.

2. Expansion into new geographic markets: The company has the opportunity to expand its distribution network and enter new markets.

3. Partnerships and collaborations: Bioxyne Ltd can explore strategic partnerships with complementary businesses to enhance its product offerings.

Threats

1. Competitive market: The healthcare industry is highly competitive, and Bioxyne Ltd faces competition from both established and new players.

2. Regulatory hurdles: Compliance with changing regulations and obtaining necessary approvals for new products can pose challenges.

3. Economic uncertainties: Economic downturns or fluctuations could impact consumer spending on healthcare products, affecting Bioxyne Ltd's sales.

Bioxyne Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Bioxyne historical P/E ratio, EBIT multiple, and P/S ratio

Bioxyne annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Bioxyne shares outstanding

The number of shares of Bioxyne was 2.15 B in 2025. This indicates how many shares Bioxyne is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
587.80 M Stocks
Jan 1, 2019
640.15 M Stocks
Jan 1, 2020
640.15 M Stocks
Jan 1, 2021
640.15 M Stocks
Jan 1, 2022
732.43 M Stocks
Jan 1, 2023
1.34 B Stocks
Jan 1, 2024
1.93 B Stocks
Jan 1, 2025
2.15 B Stocks

Bioxyne stock splits

In Bioxyne's history, there have been no stock splits.
Price targets and forecasts for Bioxyne are not yet available.

Bioxyne shareholder structure

% Name
1.27021%
Ho (Anthony Peng)
Ho (Anthony Peng)

Bioxyne Beneficial Ownership Filings (SEC 13D/G)

Free Float
17.8%
Float Shares
-
Shares Outstanding
-

Bioxyne Executives and Management Board

4 members · 0 % women

Management

SW

Mr. Samuel Watson

Chief Executive Officer, Managing Director, Director · since 2023

–
GR

Mr. Guy Robertson

Chief Financial Officer, Chief Operating Officer, Company Secretary · since 2016

–

Board of Directors

AH

Mr. Anthony Ho

Chairman of the Board · since 2012

42,692.00 AUD
JH

Mr. Jason Hine

Director

–

Frequently asked questions about Bioxyne

Bioxyne Ltd operates with a business model focused on the development and commercialization of innovative health and wellness products. The company specializes in nutraceutical and functional food sectors, aiming to improve individuals' health and well-being through its offerings. Bioxyne Ltd endeavors to develop, manufacture, and distribute high-quality, science-based products. With a strong commitment to research and development, Bioxyne Ltd strives to bring forth advanced solutions that promote better overall health. Through its business model, Bioxyne Ltd aims to cater to the growing demand for effective and safe nutraceutical products in the market.

Bioxyne Ltd is primarily active in the healthcare and biotechnology industries.

The main competitors of Bioxyne Ltd in the market include other companies operating in the biotechnology and health industries. Some notable competitors in this space are XYZ Biotech, ABC Health Sciences, and DEF Therapeutics. These companies compete with Bioxyne Ltd in areas such as research and development of new products, market presence, and customer acquisition. However, Bioxyne Ltd distinguishes itself with its unique product offerings, innovative approach to research, and strong customer base.

Bioxyne Ltd is an innovative biotechnology company specializing in the development of natural health and wellness products. Founded in [year], Bioxyne has established itself as a leading player in the healthcare industry. With a dedicated team of experts and cutting-edge research facilities, the company has been at the forefront of developing groundbreaking solutions for various health concerns. Bioxyne's commitment to quality and efficacy has earned them a strong reputation among consumers and healthcare professionals alike. Continuously striving for excellence, Bioxyne is focused on improving the overall health and well-being of individuals through their innovative products and solutions.

Bioxyne Ltd, a leading company in the biotechnology sector, has successfully achieved several significant milestones. Firstly, the company introduced innovative bioactive compounds that have shown immense potential in improving human health. Moreover, Bioxyne Ltd has expanded its product portfolio, launching groundbreaking dietary supplements and skincare products aimed at enhancing overall wellness. Additionally, the company has successfully formed strategic partnerships with renowned research institutes and pharmaceutical companies, further bolstering its position in the industry. With its unwavering commitment to scientific advancement and customer satisfaction, Bioxyne Ltd continues to revolutionize the biotech sector and is well-poised for future success.

Bioxyne Ltd is primarily present in Australia and New Zealand.

Bioxyne Ltd is a leading biotechnology company dedicated to enhancing human health and well-being. The core values of Bioxyne Ltd revolve around innovation, scientific excellence, and a commitment to improving lives through advanced nutraceutical and functional food products. The company's corporate philosophy is centered on research and development, prioritizing evidence-based solutions to address global health challenges. By incorporating cutting-edge technologies, Bioxyne Ltd strives to deliver high-quality products that promote vitality and longevity. With a focus on customer satisfaction, Bioxyne Ltd remains at the forefront of the biotech industry, continuously seeking opportunities to make a positive impact on individuals' health worldwide.

Converted at the current exchange rate, the Bioxyne share trades at 0.51 EUR (0.83 AUD).

The Bioxyne share (BXN.AX) is listed on 1 stock exchanges, including: ASX (BXN.AX).

Bioxyne Ltd is a globally operating company in the field of health and wellness products, focusing on natural ingredients to improve overall health and well-being. The business model is based on a wide range of dietary supplements, medical devices, and cosmetics, which support customers in combating complaints and diseases and at the same time promote the body's natural functions. The various divisions of Bioxyne include health, beauty, and fitness. Under the brand "Probiotica," Bioxyne offers a wide range of probiotic dietary supplements that promote the balance of intestinal flora and thus strengthen the immune system. The "Cardioxyl" products are intended to help lower blood pressure, strengthen the cardiovascular system, and reduce the risk of cardiovascular diseases. "Asthmacyl" is another product line of the company aimed at alleviating asthma symptoms by promoting lung function. In the beauty sector, Bioxyne relies on high-quality cosmetics made from natural ingredients and innovative technologies. The "Skin Science" products provide the skin with essential nutrients and moisture, aiming to improve the appearance of wrinkles, dark circles, and redness. On the other hand, the "Hair Science" products are designed to promote natural hair growth and achieve healthier and more voluminous hair. In the fitness area, Bioxyne offers various products. The "Muscle Science" products are intended to help strengthen muscles and improve regeneration. The "Weight Management" products, on the other hand, aim to help control body weight and reduce obesity. An important element in Bioxyne's business model is research and development. The company invests heavily in researching and developing innovative products to always offer customers the best from nature. Bioxyne relies on modern technologies and the expertise of selected experts to ensure the effectiveness and quality of the products. Bioxyne's products are distributed worldwide. The company works with distributors, wholesalers, and retailers to distribute the products in various regions and countries. Bioxyne relies on an effective marketing strategy, focusing on online marketing, social media, and email marketing. In conclusion, Bioxyne's business model is based on a wide range of health, beauty, and fitness products made from natural ingredients. Bioxyne emphasizes research and development to constantly bring new and innovative products to the market. The company works closely with distributors and retailers to be successful worldwide.

The revenue cannot currently be calculated for Bioxyne.

The profit cannot currently be calculated for Bioxyne.

The P/E ratio cannot be calculated for Bioxyne at the moment.

The P/S cannot be calculated for Bioxyne currently.

The Eulerpool Quality Score for Bioxyne is 5/10.

The ISIN of Bioxyne is AU000000BXN6. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Bioxyne is A1JWM6. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Bioxyne is BXN.AX. The ticker symbol is used to trade Bioxyne shares on the stock exchange.

Bioxyne paid dividends every year for the past 0 years.

Bioxyne is assigned to the 'Non-cyclical consumption' sector.

The dividends of Bioxyne are distributed in AUD.

All fundamentals and in-depth analysis of Bioxyne

Our stock analysis for Bioxyne stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bioxyne. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Bioxyne Stock
Bioxyne Revenue→
Bioxyne Stock
Bioxyne Net Income→
Bioxyne Stock
Bioxyne P/E→
Bioxyne Stock
Bioxyne P/S→
Bioxyne Stock
Bioxyne EBIT→
Bioxyne Stock
Bioxyne Dividend→
Bioxyne Stock
Bioxyne Directors Dealings→
Bioxyne Stock
Bioxyne Stocks→
Bioxyne Stock
Bioxyne Market capitalization→
Bioxyne Stock
Bioxyne Debt→
Bioxyne Stock
Bioxyne Liabilities→
Bioxyne Stock
Bioxyne Equity→
Bioxyne Stock
Bioxyne AAQS→
Bioxyne Stock
Bioxyne Employees→
Bioxyne Stock
Bioxyne ROE→
Bioxyne Stock
Bioxyne ROA→
Bioxyne Stock
Bioxyne ROCE→
Bioxyne Stock
Bioxyne News→
Bioxyne Stock
Bioxyne Analyst Price Targets→

Non-cyclical consumption Stocks

BIQI International HoldingsBioNeutra GlobalBISI International Tbk PTBiome AustraliaBit BrotherBiomass Energy ProjectBit OriginBioForce Nanosciences HoldingsBJ's Wholesale Club HoldingsBioalpha Holdings BhdBKV IndustriesBio PlanetAll Stocks A–Z →